SCHEMBL23786164

SCHEMBL23786164

O=C1CC2(c3ccc(O)cc3Cc3cc(O)ccc32)c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
LMNA P02545 3/20 0.40
MAOA P21397 3/20 0.40
MAOB P27338 3/20 0.40
GPR55 Q9Y2T6 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
POLB P06746 1/20 0.40
ALOX12 P18054 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTT P42858 1/20 0.40
RECQL P46063 1/20 0.40
BLM P54132 1/20 0.40
SMAD3 P84022 1/20 0.40
PRMT1 Q99873 1/20 0.40
ACE2 Q9BYF1 1/20 0.40
FTO Q9C0B1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22704774 0.81 FTO (0.58) MAPTLMNAMAOAMAOBGPR55
SCHEMBL26418475 0.78 MAPK14 (0.41) MAPTLMNAMAOAMEN1KMT2A
SCHEMBL14462993 0.77 S100A4 (0.42) MEN1KMT2ATDP1POLBALDH1A1
SCHEMBL6552460 0.74 ESR1 (0.51) MAPTLMNAGPR55MEN1KMT2A
SCHEMBL12715262 0.73 MAPT (0.68) MAPTLMNAGPR55MEN1KMT2A
SCHEMBL7044120 0.70 DRD2 (0.53) LMNAMAOAMAOBPBRM1DRD2
SCHEMBL23786319 0.70 HSD17B1 (0.35) MAOAMAOBPBRM1ESR1ESR2
SCHEMBL15676305 0.69 MAOA (0.67) MAPTMAOAMAOBMEN1KMT2A
SCHEMBL30074263 0.69 CFTR (0.48) MAPTLMNAGPR55MEN1KMT2A
SCHEMBL181563 0.69 CFTR (0.48) MAPTLMNAGPR55MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827624-B2 Covalent immune recruiter compounds for immune cell recognition and associated uses MCMASTER UNIVERSITY (CA) 2023-11-28 US disclosed
US-11827624-B2 Covalent immune recruiter compounds for immune cell recognition and associated uses MCMASTER UNIVERSITY (CA) 2023-11-28 US disclosed
US-20210276981-A1 COVALENT IMMUNE RECRUITER COMPOUNDS FOR IMMUNE CELL RECOGNITION AND ASSOCIATED USES MCMASTER UNIVERSITY (CA) 2021-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827624-B2 Covalent immune recruiter compounds for immune cell recognition and associated uses CD74, CD4, HLA-A MAPT 875/4885LMNA 3035/4885MAOA 1649/4885
US-20210276981-A1 COVALENT IMMUNE RECRUITER COMPOUNDS FOR IMMUNE CELL RECOGNITION AND ASSOCIATED USES CD74, CD4, HLA-A MAPT 1211/4885LMNA 1224/4885MAOA 1535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.